FDA Seeks Advice on Researching Drug Risks in Pregnancy
The FDA held a workshop on ways to improve collection of safety data on medicines used during pregnancy and released guidance for companies on postapproval pregnancy safety studies. Medscape Medical News
Original Source
Read the full article at Medscape →KhanList aggregates and links to publicly available news content. We do not host full articles from third-party sources. Always verify important information with original sources.